GENET-news
To stay informed you can subscribe to the GENET-news list.
2006-12-18 | permalink
Fraunhofer CMB receives Gates Foundation grant to develop innovative malaria vaccines
The Fraunhofer USA Center for Molecular Biotechnology ("Fraunhofer CMB") announced today the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to support the development of transmission-blocking vaccines against malaria. To achieve the goals of this project, Fraunhofer CMB will employ its proprietary platform technology to produce lifesaving vaccines in non-genetically modified plants. [...] This is the third grant that Fraunhofer CMB has received from the Bill & Melinda Gates Foundation to support development of vaccines using its plant- based platform. A $2.7 million award for development of novel subunit vaccines against influenza was announced last week. Fraunhofer CMB was also the recipient of a $1.2 million Gates Foundation grant in 2005 for pre-clinical studies towards the development of a vaccine against African trypanosomiasis.
- DrugNewswire, USA: Fraunhofer CMB receives Gates Foundation grant to develop innovative malaria vaccines
- Fraunhofer Center for Molecular Biology, USA: Fraunhofer USA: Molecular Farming
- Fraunhofer Center for Molecular Biology, USA: Fraunhofer USA: Vaccine Development
- Voice of America, USA: Scientists explore new approaches to fight malaria
Overview
News
2006-12-18 | permalink
Fraunhofer CMB receives Gates Foundation grant to develop innovative malaria vaccines
The Fraunhofer USA Center for Molecular Biotechnology ("Fraunhofer CMB") announced today the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to support the development of transmission-blocking vaccines against malaria. To achieve the goals of this project, Fraunhofer CMB will employ its proprietary platform technology to produce lifesaving vaccines in non-genetically modified plants. [...] This is the third grant that Fraunhofer CMB has received from the Bill & Melinda Gates Foundation to support development of vaccines using its plant- based platform. A $2.7 million award for development of novel subunit vaccines against influenza was announced last week. Fraunhofer CMB was also the recipient of a $1.2 million Gates Foundation grant in 2005 for pre-clinical studies towards the development of a vaccine against African trypanosomiasis.
- DrugNewswire, USA: Fraunhofer CMB receives Gates Foundation grant to develop innovative malaria vaccines
- Fraunhofer Center for Molecular Biology, USA: Fraunhofer USA: Molecular Farming
- Fraunhofer Center for Molecular Biology, USA: Fraunhofer USA: Vaccine Development
- Voice of America, USA: Scientists explore new approaches to fight malaria
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.